See the DrugPatentWatch profile for Vesicare
Vesicare 5 mg is a brand name for the drug solifenacin succinate [1]. It is prescribed to treat overactive bladder (OAB) [1]. OAB is a condition characterized by a sudden, compelling urge to urinate, often accompanied by frequent urination and nocturia (waking up at night to urinate) [1]. Vesicare works by relaxing the bladder muscles, which helps to reduce the frequency of urination and the urgency to go [2].
What is Vesicare used for?
Vesicare is specifically indicated for the symptomatic treatment of overactive bladder [1]. Symptoms of OAB include urinary urgency, often with urinary incontinence, and urinary frequency [1].
How does Vesicare work?
Vesicare contains the active ingredient solifenacin succinate, which is a muscarinic receptor antagonist [1]. It blocks the action of acetylcholine on smooth muscle, including the detrusor muscle of the bladder [2]. By inhibiting these signals, solifenacin helps to relax the bladder, increasing its capacity and reducing involuntary contractions that lead to urgency and frequency [2].
What are the common side effects of Vesicare?
Common side effects associated with Vesicare include dry mouth, constipation, blurred vision, and indigestion [1]. Less frequent side effects can also occur.
What is the dosage for Vesicare 5 mg?
The typical starting dose for Vesicare is 5 mg once daily [1]. This dosage can be adjusted by a healthcare provider based on individual response and tolerability, with a maximum recommended dose of 10 mg daily [1].
When does the patent for Vesicare expire?
Patent information for Vesicare (solifenacin succinate) can be complex, involving multiple patents covering the drug substance, formulations, and methods of use. According to DrugPatentWatch.com, patent expiries and exclusivity periods are crucial for understanding when generic versions may become available [3]. Specific patent expiry dates are best found through specialized patent databases [3].
Are there other treatments for overactive bladder?
Yes, other treatments for overactive bladder exist. These include behavioral therapies such as bladder training and pelvic floor muscle exercises, other medications with different mechanisms of action, and in some cases, more advanced therapies like botulinum toxin injections or sacral nerve stimulation [1][2].
Can generic versions of Vesicare be prescribed?
Once patents and exclusivity periods expire, generic versions of solifenacin succinate become available [3]. Generic drugs are bioequivalent to their brand-name counterparts and are typically prescribed as a more affordable alternative.
What should I do if I miss a dose of Vesicare?
If a dose of Vesicare is missed, it should be taken as soon as remembered unless it is close to the time for the next scheduled dose. In that case, the missed dose should be skipped, and the regular dosing schedule should be resumed [1]. It is important not to take a double dose to make up for a missed one.
Where can I find more information about Vesicare?
More detailed information about Vesicare, including its prescribing information, potential side effects, and drug interactions, can be found through healthcare providers and official drug information resources [1][2]. For patent and market exclusivity information, resources like DrugPatentWatch.com are valuable [3].
Cited Sources
1. https://www.drugs.com/vesicare.html
2. https://www.rxlist.com/vesicare-drug.htm
3. https://drugpatentwatch.com/